External preparations for skin containing calcium receptor active compounds

A technology for external preparations and calcium receptors, which can be used in medical preparations containing active ingredients, medical preparations without active ingredients, and organic active ingredients, etc. Difficulty and other problems, to achieve the effect of drug treatment, reduce the number of doses, and facilitate use
CN106890166BActive Publication Date: 2020-02-18BEIJING TIDE PHARMA
3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
BEIJING TIDE PHARMA
Publication Date
2020-02-18

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a skin external use preparation containing a calcium receptor activity compound. The preparation avoids hepatic first pass effect and gastrointestinal adverse reactions of an oral preparation. The preparation comprises a medicine active component, a high-molecular gel skeleton, a tackifier, a moisturizer, and other pharmaceutically acceptable excipients. The preparation has high drug load and is free of problems of irritation and allergy, has no crystallization phenomenon, has better stability and is more safe and convenient to use.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of pharmaceutical preparations, in particular to an external skin preparation containing a calcium receptor active compound. Background technique

[0002] Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD). Chronic kidney disease leads to abnormal mineral and bone metabolism in patients, and its severity mainly leads to cardiovascular calcification. closely related to survival. Active vitamin D drugs used in the clinical treatment of secondary hyperparathyroidism are often accompanied by hypercalcemia and hyperphosphatemia, which increase the risk of cardiovascular calcification. Most patients with secondary hyperparathyroidism who do not respond to medical treatment can only receive parathyroidectomy. The advent of calcium receptor active compounds has changed the risk of surgery in patients with secondary hyperparathyroidism, making most patients with severe secondary hyp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More